Baskhanbio Pharma Inc. (XKON:354390)
5,290.00
+20.00 (0.38%)
At close: Jul 4, 2025, 3:30 PM KST
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 37.20 billion as of July 7, 2025. Its market cap has decreased by -17.96% in one year.
Market Cap
37.20B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,290.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 37.20B, a decrease of -55.08%. That is a compound annual growth rate of -23.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 7, 2025 | 37.20B | 23.54% |
Dec 30, 2024 | 30.11B | -36.91% |
Dec 28, 2023 | 47.72B | 16.64% |
Dec 29, 2022 | 40.92B | -50.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 414.65T |
SK hynix | 186.74T |
Samsung Biologics | 73.88T |
LG Energy Solution | 72.66T |
Hyundai Motor Company | 45.94T |
KB Financial Group | 40.82T |
Celltrion | 39.31T |
Kia Corporation | 38.63T |